|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -75.00% |
| 04-02 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026 | CI |
| 03-05 | RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025 | CI |
| Market Cap | 1.79M 1.28M 1.1M 1.02M 953K 121M 1.81M 12.01M 4.69M 59.29M 4.81M 4.71M 205M | P/E Ratio 2024 |
-0.07x | P/E Ratio 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 764K 658K 606K 568K 72.16M 1.08M 7.16M 2.8M 35.34M 2.87M 2.8M 122M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -40.00% | ||
| Current year | -75.00% |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.05 | |
| 1 year | 0.01 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 21/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +50.00% | -70.00% | 1.28M | ||
| -0.32% | -1.72% | +37.83% | +148.79% | 1,007B | ||
| -2.16% | +1.51% | +50.01% | +43.93% | 567B | ||
| -2.70% | -0.66% | +15.97% | +63.07% | 392B | ||
| -0.28% | +1.05% | +20.91% | +18.37% | 328B | ||
| -0.46% | +1.13% | +24.23% | +31.91% | 277B | ||
| +0.83% | -2.38% | +23.02% | +12.89% | 275B | ||
| -0.45% | +5.21% | -43.07% | -48.62% | 196B | ||
| -1.31% | +1.39% | +18.74% | +53.45% | 189B | ||
| -1.03% | -2.97% | +13.02% | +57.34% | 154B | ||
| Average | +0.11% | +0.30% | +21.06% | +31.11% | 338.6B | |
| Weighted average by Cap. | +0.23% | -0.03% | +26.50% | +67.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.11M 2.68M 2.46M 2.31M 294M 4.39M 29.13M 11.38M 144M 11.66M 11.41M 497M | 3.36M 2.4M 2.07M 1.91M 1.79M 227M 3.39M 22.55M 8.81M 111M 9.02M 8.83M 385M |
| Net income | -16.5M -11.81M -10.18M -9.36M -8.79M -1.12B -16.67M -111M -43.24M -546M -44.3M -43.36M -1.89B | -8.91M -6.37M -5.49M -5.06M -4.74M -602M -9M -59.77M -23.35M -295M -23.92M -23.41M -1.02B |
| Net Debt | -626K -448K -386K -355K -333K -42.31M -632K -4.2M -1.64M -20.72M -1.68M -1.64M -71.69M | -723K -518K -446K -411K -385K -48.91M -731K -4.85M -1.9M -23.95M -1.94M -1.9M -82.89M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















